血液辐照市场战略、顶级参与者、增长机会、2028 年分析和预测

  • Report Code : TIPRE00003256
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 170
Buy Now

Blood Irradiation Market Size, Share | Industry Trends 2022, 2028

Buy Now

 

血液辐照市场规模预计将从 2021 年的 6515 万美元增至 2028 年的 1.0437 亿美元;预计 2022 年至 2028 年的复合年增长率为 7.0%。

传染性和非传染性疾病的发病率不断上升,以及研发的不断增加推动了市场的增长。然而,血液辐照的高成本限制了市场的增长。

血液辐照是通过在血管中心将血液暴露于至少 25 Gy (2500 cGy) 的辐射来实现的,从而阻止具有免疫能力的供体 T 白细胞在接受者的体内复制和植入。由供体移植引起的 GvHD 几乎总是致命的,因此有风险的患者应在时间和资源允许的情况下接受辐照血液制品。临床适应症需要血液辐照治疗,包括急性白血病、淋巴瘤、接受强化化疗或放射治疗的实体瘤、换血、器官移植接受者和早产儿。感染人类免疫缺陷病毒/获得性免疫缺陷综合征的患者不需要血液制品辐照,因为据报告他们不易患输血后移植物宿主疾病。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

血液辐照市场:

血液辐照市场
  • Blood Irradiation Market
    复合年增长率(2021 - 2028 年)
    7.0%
  • 2021 年市场规模
    6515 万美元
  • 市场规模 2028 年
    1.0437 亿美元

市场动态

增长动力
  • 財政部
  • 財政部
  • 財政部
未来的趋势
  • 財政部
  • 財政部
  • 財政部
机会
  • 財政部
  • 財政部
  • 財政部

关键人物;主力;重要一员

  •  
  • Typenex 医疗有限公司
  • 日立医疗系统
  • 辐射源技术
  • 吉拉多尼公司
  • Gamma-Service Medical GmbH
  • 阿克泰姆
  • 最佳Theratronics有限公司

区域概况

Blood Irradiation Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Blood Irradiation Market类型
  • 静脉激光血液照射
  • 经皮激光血液照射
  • 体外血液辐照
Blood Irradiation Market指征
  • 急性白血病
  • 淋巴瘤
  • 实体肿瘤
  • 盆腔肿瘤
  • 其他的
Blood Irradiation Market最终用户
  • 医院
  • 血库
  • 诊断诊所
  • 研究机构
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

市场洞察

 

传染性和非传染性疾病患病率上升推动市场增长

由于全球有大量人口易患癌症、心血管疾病、慢性肾病和中风等传染性和非传染性疾病,因此这些疾病的发病率有所增加。根据世界卫生组织 (WHO) 的数据,心血管疾病是全球最大的死亡原因,每年报告的死亡人数约为 1790 万人。此外,肝炎、流感、人类免疫缺陷病毒 (HIV) 和获得性免疫缺陷综合征 (AIDS) 等传染病的患病率不断上升,正在推动血液辐照市场的增长据世卫组织称,2020 年有 3.25 亿人感染乙型肝炎病毒,每年有 90 万人死于乙型肝炎病毒感染。此外,世界各地大量的老年人口也导致了心血管疾病、肾脏疾病和中风等非传染性疾病的流行。据世界卫生组织统计,2019年60岁及以上人口为10亿,预计到2030年将增至14亿,到2050年将增至21亿。老年人口由于营养不良、缺乏运动、过度吸烟和饮酒等各种因素而容易患上非传染性疾病。

此外,由于外科手术、事故、创伤病例和疾病的增加,以及血液感染患病率的上升,输血量激增,这也推动了市场的增长。血液感染、潜在疾病和侵入性手术在老年人中很常见。血液感染是导致大量人群患病和死亡的主要原因。根据美国国家医学图书馆的数据,全球每年发生约 28,000 例血液感染。此外,人们对血液感染的认识不断提高,对输血的免疫反应不断增强,这可能会导致并发症,因为在癌症治疗中越来越多地使用辐照血液可以增强免疫系统并改善患者的整体健康状况,从而推动血液辐照市场的增长。

因此,传染性和非传染性疾病患病率的增加、输血量的增加、血流感染的激增以及免疫反应的增强正在推动血液辐照市场的增长。

 

基于类型的洞察

根据类型,血液照射市场分为静脉激光血液照射、经皮激光血液照射和体外血液照射。 2021 年,静脉激光血液照射部分占据最大市场份额。 然而,体外激光血液照射部分预计在预测期内将录得最高复合年增长率 7.8%。

 

基于最终用户的洞察   

根据最终用户,血液辐照市场分为医院、血库、诊断诊所和研究机构。医院部门在 2021 年占据了最大的市场份额。然而,预计血库部门在预测期内的复合年增长率最高,为 7.7%。

 

血液辐照市场报告范围

报告属性细节
2021 年市场规模6,515万美元
2028 年市场规模1.0437亿美元
全球复合年增长率(2021 - 2028)7.0%
历史数据2019-2020
预测期2022-2028
涵盖的领域按类型
  • 静脉激光血液照射
  • 经皮激光血液照射
  • 体外血液辐照
按适应症
  • 急性白血病
  • 淋巴瘤
  • 实体肿瘤
  • 盆腔肿瘤
  • 其他的
按最终用户
  • 医院
  • 血库
  • 诊断诊所
  • 研究机构
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • Typenex 医疗有限公司
  • 日立医疗系统
  • 辐射源技术
  • 吉拉多尼公司
  • Gamma-Service Medical GmbH
  • 阿克泰姆
  • 最佳Theratronics有限公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

基于指示的见解

根据适应症,血液照射市场分为急性白血病、实体瘤、盆腔肿瘤、淋巴瘤等。急性白血病领域在 2021 年占据了最大的市场份额。然而,预计在预测期内,淋巴瘤领域的复合年增长率最高,为 8.8%。

血液辐照市场中的公司采用产品创新战略来满足全球不断变化的客户需求,这也使他们能够在全球市场上保持自己的品牌名称。例如,2021 年 6 月,美国商业 X 射线辐射产品供应商 Rad Source Technologies 设计了一款产品来取代自屏蔽伽马辐照器,并在 2021 年中东 MEDLAB 展会上推出了其新设计的 RS 3400 血液辐照器。

 

血液辐照市场 – 按地区划分

从地理上看,血液辐照市场分为北美(美国、加拿大和墨西哥)、欧洲(法国、德国、英国、西班牙、意大利和欧洲其他地区)、亚太地区(中国、印度、日本、澳大利亚、韩国和亚太地区其他地区)、中东和非洲(沙特阿拉伯、阿联酋、南非和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。Typenex Medical, LLC;日立医疗系统;Rad Source Technologies;Gilardoni SpA;Gamma-Service Medical GmbH;Actemium;和 Best Theratronics Ltd. 是本研究涉及的市场参与者。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the regional market scenario of the blood irradiation market?

Global blood irradiation market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. In North America, the U.S. held the largest market share for blood irradiation market. The US is estimated to hold the largest share in the blood irradiation market during the forecast period. Increase in R&D activities along with surge in autoimmune disorders and organ transplants are the contributing factors for the regional growth. Additionally, increase in communicable and non-communicable diseases is the key factor responsible for the Asia-Pacific regional growth for blood irradiation accounting fastest growth of the region during the coming years.

Who are the key players in the blood irradiation market?

Typenex Medical, LLC; Hitachi Medical Systems; Rad Source Technologies; Gilardoni S.p.A.; Gamma-Service Medical GmbH; Actemium; Best Theratronics Ltd. are among the leading companies operating in the global blood irradiation market

Which indication segment held the largest revenue (US$ Mn) in the blood irradiation market?

The acute leukemia segment dominated the global blood irradiation market and accounted for the largest revenue of 26.93 Mn in 2021.

What is meant by the blood irradiation market?

Blood irradiation is the process in which blood is exposed to low level of radiation which deactivates the T lymphocytes and inhibits the immune response for the prevention of rare graft-versus-host disease (GVHD). This therapy is also used for the treatment of various disorders such as autoimmune disorders, cancer, neuropathies and many more.

What are the driving factors for the blood irradiation market across the globe?

Increase in communicable and non-communicable diseases, rise in healthcare expenditure, and government initiatives are the most significant factors responsible for the overall market growth.

Which segment led the blood irradiation market?

Based on type, intravenous laser blood irradiation took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.

The List of Companies - Blood Irradiation Market

  1. Typenex Medical, LLC
  2. Hitachi Medical Systems
  3. Rad Source Technologies
  4. Gilardoni S.p.A.
  5. Gamma-Service Medical GmbH
  6. Actemium
  7. Best Theratronics Ltd.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Medical Device : READ MORE..